Journal of Parathyroid Disease最新文献_第5页

Clinical characteristics of hospitalized patients with COVID-19: Results from multiple-center experience in Ardabil, Northwest of Iran 新冠肺炎住院患者的临床特征:来自伊朗西北部阿达比尔多中心经验的结果

Journal of Parathyroid Disease Pub Date : 2023-02-12 DOI: 10.34172/jpd.2023.11192

S. Matin, Hassan Ghobadi, E. Safarzadeh, Leila Torabi Marjin, Masoomeh Dadkhah

{"title":"Clinical characteristics of hospitalized patients with COVID-19: Results from multiple-center experience in Ardabil, Northwest of Iran","authors":"S. Matin, Hassan Ghobadi, E. Safarzadeh, Leila Torabi Marjin, Masoomeh Dadkhah","doi":"10.34172/jpd.2023.11192","DOIUrl":"https://doi.org/10.34172/jpd.2023.11192","url":null,"abstract":"Introduction: Since December 2019, coronavirus disease 2019 (COVID-19) has rapidly expanded to cause a worldwide pandemic. Objectives: We aimed to report the clinical characteristics of infected patients at the first wave in northwest of Iran. Patients and Methods: In this study, the epidemiological, demographic, clinical, and laboratory data of 1152 confirmed patients with COVID-19 who were admitted to two main hospitals at the first outbreak in northwest of Iran were collected and analyzed. Results: The most common clinical manifestations at onset were cough (65.8%), dyspnea (40.2%), myalgia (37.8%), and fever (63.4%), loss of appetite (47%), chest pain (38.6%), and headache (49.4%). While the less common were agitation (17.3%), vomiting (22.2%), diarrhea (16.7%), and nausea (24.3%). Laboratory data indicated significant correlation between lymphocyte counts with the severity of the disease based on O2 saturation. Conclusion: Overall, assessment the clinical data of COVID-19 patients play a crucial role in understanding the outbreak of novel viral pneumonia, which helps to identify high risk individuals with COVID-19.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84234598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An overview on acute kidney injury following COVID-19 COVID-19后急性肾损伤综述

Journal of Parathyroid Disease Pub Date : 2023-02-09 DOI: 10.34172/jpd.2023.11179

Mohammad-Reza Hajian, M. Momenzadeh

引用次数: 0

Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients 评估降低尿酸水平对血液透析患者血清维生素D水平的影响

Journal of Parathyroid Disease Pub Date : 2023-01-09 DOI: 10.34172/jpd.2023.11194

Negar Karevan, Saeed Mardani, Sara Karevan, H. Mardanparvar, Maryam Ghasemi, Mohammad-Seddigh Ghaffari

{"title":"Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients","authors":"Negar Karevan, Saeed Mardani, Sara Karevan, H. Mardanparvar, Maryam Ghasemi, Mohammad-Seddigh Ghaffari","doi":"10.34172/jpd.2023.11194","DOIUrl":"https://doi.org/10.34172/jpd.2023.11194","url":null,"abstract":"Introduction: The role of vitamin D in metabolism, bone-mineral regulation, and anti-oxidation effect has drawn researchers’ attention toward its exact role in hemodialysis. Objectives: In this study, the effect of uric acid level reduction on serum 25-hydroxy vitamin D levels in hemodialysis patients was assessed. Patients and Methods: This study is a triple-blind clinical trial conducted on 81 hemodialysis patients suffering from asymptomatic hyperuricemia. Serum uric acid levels were assessed at the start of the study. Then patients were divided randomly into two groups of intervention and control. The intervention group received 100 mg of allopurinol tablets daily for two months. The control group received placebo tablets for the same duration. At the end of the study, 25-hydroxyvitamin D and uric acid levels were assessed. Data were analyzed using SPSS software and chi-square, independent t test, Mann–Whitney U, and Spearman’s rank correlation tests. Results: In our study, two groups of control and intervention were similar in terms of patients’ demographic and hemodialysis characteristics. After the intervention, compared to the control group, the serum uric acid levels were significantly lower in the intervention group, while the level of 25-hydroxyvitamin D showed no significant difference between the two groups. Conclusion: In this study, no significant effect of uric acid lowering therapy with vitamin D elevation in hemodialysis patients was detected. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT2015041721803N1; https:// en.irct.ir/trial/18996, ethical code#IR.SKUMS.1395.231).","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81154776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Possible cancer enhancement impact of parathyroid hormone excess 甲状旁腺激素过量可能对癌症的增强作用

Journal of Parathyroid Disease Pub Date : 2023-01-07 DOI: 10.34172/jpd.2023.11195

M. Dehghani, Narges Esmaeili, M. Khosravian, H. Nasri

引用次数: 0

Goiter size changes as an indicator of response to treatment following selenium intake, and its correlation with goiter type 甲状腺肿大变化作为硒摄入后对治疗反应的指标，及其与甲状腺肿大类型的相关性

Journal of Parathyroid Disease Pub Date : 2023-01-07 DOI: 10.34172/jpd.2023.11182

S. Kalbasi, H. Mardanparvar, A. Tajik, Danial Khazaeian, Ali Neyriz, F. Farsad, S. Ahmadi

{"title":"Goiter size changes as an indicator of response to treatment following selenium intake, and its correlation with goiter type","authors":"S. Kalbasi, H. Mardanparvar, A. Tajik, Danial Khazaeian, Ali Neyriz, F. Farsad, S. Ahmadi","doi":"10.34172/jpd.2023.11182","DOIUrl":"https://doi.org/10.34172/jpd.2023.11182","url":null,"abstract":"Introduction: Goiter is a common problem in the world; however, it is more prevalent in countries with iodine deficiency. Goiter has different etiologies while one of them is Hashimoto’s thyroiditis. Selenium is a trace element that has different important effects in the body. It has also some effects in the thyroid. Objectives: This study aimed to evaluate the effect of selenium intake on goiter size and the correlation with goiter type. Patients and Methods: In prospective observational study, 20 patients with Hashimoto’s goiter and 40 patients with non-Hashimoto’s goiter were evaluated for thyroid sizes. The nodule sizes were else evaluated. After the first evaluation, daily selenium supplement (200 mg) was prescribed for all patients for six months. After this time, the sizes of goiter and nodules were measured again. Results: Results showed that the size of both goiter lobes in both Hashimoto’s and non-Hashimoto’s groups was significantly reduced before and after selenium intake (P<0.001). The reduction rate in left lobe size in patients with Hashimoto’s goiter was 50.73% and in nonHashimoto’s goiter patients was 20.89% (P<0.001). The reduction rate in right lobe size in patients with Hashimoto’s goiter was 53.37% and in non-Hashimoto’s goiter was 20.46 (P<0.001). Conclusion: We conclude that administration of selenium is effective in reducing the size of the goiter.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72761060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Glomerulonephritis and impact of vitamin D; a short look to the recent evidence 肾小球肾炎及维生素D的影响我们来看看最近的证据

Journal of Parathyroid Disease Pub Date : 2023-01-07 DOI: 10.34172/jpd.2023.11196

M. Dehghani, H. Nasri

引用次数: 0

Zinc level alternation after phototherapy in neonates with hyperbilirubinemia 高胆红素血症新生儿光疗后锌水平的变化

Journal of Parathyroid Disease Pub Date : 2023-01-04 DOI: 10.34172/jpd.2023.11193

Rakhshaneh Goodarzi, S. Saadat, Fatemeh Janbozorgi, Behnaz Darban

{"title":"Zinc level alternation after phototherapy in neonates with hyperbilirubinemia","authors":"Rakhshaneh Goodarzi, S. Saadat, Fatemeh Janbozorgi, Behnaz Darban","doi":"10.34172/jpd.2023.11193","DOIUrl":"https://doi.org/10.34172/jpd.2023.11193","url":null,"abstract":"Introduction: One of the old treatment methods for unconjugated hyperbilirubinemia in neonates is blood exchange transfusion, which is expensive, possibly high-risk, and time-consuming. Today phototherapy as a novel method can be a good alternative. Objectives: This study aimed to evaluate the zinc level alternation after phototherapy in neonates with hyperbilirubinemia. Patients and Methods: A descriptive-analytical study was conducted on 85 infants with hyperbilirubinemia who underwent phototherapy referred to the pediatric hospital in Bandar- Abbas, Iran from 2017 to 2018. Healthy infants over two days with idiopathic jaundice with a gestational age greater than 34 weeks and only breast-feed were enrolled. Serum zinc levels were measured before and after phototherapy, and their changes were evaluated. Results: Out of 85 neonates, 42 (49.4%) were male and 43 (50.6%) were female with a mean gestational age of 37.83 ± 0.58 weeks and admission age of 4.15 ± 1.70 days. Zinc level before phototherapy was 84.98 ± 52.06 (μg/dL) and after phototherapy was 234.41 ± 280.98. The difference between serum zinc levels before and after the phototherapy was significant therefore, the zinc level significantly increased after the phototherapy. Conclusion: Results showed that phototherapy increases serum zinc levels, which can cause zinc toxicity. It is wise to measure serum zinc levels before and during phototherapy and seek the appropriate medical care.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78848575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Thyroid status and severity or mortality of COVID-19 甲状腺状况与COVID-19的严重程度或死亡率

Journal of Parathyroid Disease Pub Date : 2022-11-03 DOI: 10.34172/jpd.2022.11187

A. Hassanzadeh Rad, Amirhossein Fakhre Yaseri

引用次数: 1

Lithium therapy and parathyroid gland interaction 锂治疗与甲状旁腺的相互作用

Journal of Parathyroid Disease Pub Date : 2022-11-01 DOI: 10.34172/jpd.2022.11178

R. Tolouian, A. Baradaran

引用次数: 0

COVID-19 and red cell distribution width COVID-19和红细胞分布宽度

Journal of Parathyroid Disease Pub Date : 2022-11-01 DOI: 10.34172/jpd.2022.11184

A. Baradaran, Narges Esmaeili

引用次数: 0